000 | 01961 a2200541 4500 | ||
---|---|---|---|
005 | 20250514002657.0 | ||
264 | 0 | _c20010802 | |
008 | 200108s 0 0 eng d | ||
022 | _a1524-4571 | ||
024 | 7 |
_a10.1161/hh1201.091960 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWaypa, G B | |
245 | 0 | 0 |
_aModel for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. _h[electronic resource] |
260 |
_bCirculation research _cJun 2001 |
||
300 |
_a1259-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntimycin A _xpharmacology |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aElectron Transport _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aHypoxia _xmetabolism |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aIon Channels _xdrug effects |
650 | 0 | 4 |
_aLung _xblood supply |
650 | 0 | 4 | _aMethacrylates |
650 | 0 | 4 |
_aMitochondria _xdrug effects |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xcytology |
650 | 0 | 4 |
_aOnium Compounds _xpharmacology |
650 | 0 | 4 |
_aOxygen _xmetabolism |
650 | 0 | 4 |
_aPulmonary Artery _xcytology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 |
_aRotenone _xpharmacology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aThiazoles _xpharmacology |
650 | 0 | 4 |
_aUncoupling Agents _xpharmacology |
650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
700 | 1 | _aChandel, N S | |
700 | 1 | _aSchumacker, P T | |
773 | 0 |
_tCirculation research _gvol. 88 _gno. 12 _gp. 1259-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/hh1201.091960 _zAvailable from publisher's website |
999 |
_c11349997 _d11349997 |